21:04
2026-05-10
bigpharmasharma.com
ai-startups
Last Week Tonight in BioPharma: Week of May 4th
Cytokinetics’ aficamten met both primary and secondary endpoints in a Phase 3 trial for non-obstructive hypertrophic cardiomyopathy, positioning the drug for a potential regulatory filing and setting …